Skip to main content
. 2019 Nov 26;20(23):5942. doi: 10.3390/ijms20235942
CAR Chimeric antigen receptor
ATT Adoptive T-cell therapy
ALL Acute lymphoblastic leukemia
DLBCL Diffuse large B-cell lymphoma
CSPG4 Chondroitin sulfate proteoglycan 4
scFv Single-chain Fragment variable
FDA Food and drug administration
EMA European medicines agency
TME Tumor microenvironment
MCSP Melanoma-associated chondroitin sulfate proteoglycan
HMW-MAA High molecular weight melanoma-associated antigen
NG2 Neural/glial antigen 2
GAG Glycosaminoglycan
CS Chondroitin sulfate
RTK Receptor tyrosine kinases
PKCα Protein kinase C alpha
MAPK Mitogen-activated-protein-kinase
FAK Focal adhesion kinase
TIL Tumor-infiltrating lymphocyte
r/r refractory and relapsing
FLT3 FMS-like tyrosine kinase 3
FLT3-ITD FLT3 with internal tandem duplication
HSC Hematopoietic stem cell
MLL Mixed lineage leukemia
GBM Glioblastoma
BiTE Bi-specific T-cell engager
GSC Glioblastoma stem cell
EGR1 Early growth response protein 1
TNBC Triple-negative breast cancer
ER estrogen receptors
EGFR epidermal growth factor receptor
VEGFRvIII Vascular endothelial growth factor receptor variant III
PARP Poly(ADP-ribose) polymerase